VCG
Vantage Consulting Group’s CVS Health CVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,319
| Closed | -$609K | – | 46 |
|
|
2024
Q2 | $609K | Buy |
10,319
+1,879
| +22% | +$111K | 0.45% | 18 |
|
|
2024
Q1 | $673K | Buy |
8,440
+127
| +2% | +$10.1K | 0.43% | 17 |
|
|
2023
Q4 | $656K | Sell |
8,313
-1,656
| -17% | -$131K | 0.44% | 17 |
|
|
2023
Q3 | $696K | Buy |
9,969
+890
| +10% | +$62.1K | 0.47% | 14 |
|
|
2023
Q2 | $628K | Buy |
9,079
+273
| +3% | +$18.9K | 0.36% | 14 |
|
|
2023
Q1 | $654K | Buy |
8,806
+2,066
| +31% | +$154K | 0.37% | 14 |
|
|
2022
Q4 | $628K | Sell |
6,740
-387
| -5% | -$36.1K | 0.37% | 14 |
|
|
2022
Q3 | $680K | Sell |
7,127
-184
| -3% | -$17.6K | 0.4% | 13 |
|
|
2022
Q2 | $677K | Buy |
7,311
+1,027
| +16% | +$95.1K | 0.38% | 12 |
|
|
2022
Q1 | $636K | Sell |
6,284
-1,166
| -16% | -$118K | 0.25% | 14 |
|
|
2021
Q4 | $769K | Sell |
7,450
-794
| -10% | -$82K | 0.21% | 15 |
|
|
2021
Q3 | $700K | Buy |
8,244
+283
| +4% | +$24K | 0.15% | 15 |
|
|
2021
Q2 | $664K | Buy |
7,961
+1,461
| +22% | +$122K | 0.12% | 17 |
|
|
2021
Q1 | $489K | Buy |
6,500
+1,985
| +44% | +$149K | 0.1% | 16 |
|
|
2020
Q4 | $308K | Buy |
+4,515
| New | +$308K | 0.03% | 16 |
|